Australia markets closed

Structure Therapeutics Inc. (GPCR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.96-3.72 (-8.52%)
At close: 04:00PM EDT
41.85 +1.89 (+4.73%)
Pre-market: 08:09AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-56.391
-89,620
-51,321
-40,008
-16,039
Depreciation & amortisation
0.271
295
277
72
0
Stock-based compensation
2.828
8,191
2,514
1,487
570
Change in working capital
4.937
6,966
2,968
4,062
946
Accounts payable
3.363
-860
2,153
1,897
1,020
Other working capital
-45.057
-81,655
-46,275
-33,366
-14,302
Other non-cash items
0.336
655
347
241
43
Net cash provided by operating activities
-44.853
-79,488
-46,120
-32,160
-14,283
Cash flows from investing activities
Investments in property, plant and equipment
-0.204
-2,167
-155
-1,206
-19
Purchases of investments
-114.265
-417,356
-123,453
-4,212
-21,128
Sales/maturities of investments
43.1
151,181
61,500
23,277
0
Net cash used for investing activities
-71.369
-268,342
-62,108
17,859
-21,147
Cash flows from financing activities
Common stock issued
300,000
472,296
0
-
-
Other financing activities
-19,017
-21,565
-2,519
-115
-
Net cash used provided by (used for) financing activities
29.215
451,531
29,014
103,254
25,837
Net change in cash
-87.007
103,701
-79,214
88,953
-9,593
Cash at beginning of period
115.099
26,091
105,305
16,352
25,945
Cash at end of period
28.092
129,792
26,091
105,305
16,352
Free cash flow
Operating cash flow
-44.853
-79,488
-46,120
-32,160
-14,283
Capital expenditure
-0.204
-2,167
-155
-1,206
-19
Free cash flow
-45.057
-81,655
-46,275
-33,366
-14,302